Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05845476 · ClinicalTrials.gov registry record

Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation

A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
54
Enrollment target

NCT05845476 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 54 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05845476 has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
54 participants
Enrollment target

Study Summary

Sexual and gender minority (SGM) individuals experience significant cancer-related health disparities across the cancer continuum. The overall goal of this proposal is to assess multi-level barriers associated with sexual orientation and gender identity (SOGI) data collection in the health record as well as implementation factors including feasibility, acceptability, and data completeness. The results of this study will make a significant impact by making SOGI data available for research, addressing barriers to SOGI data collection in a large comprehensive cancer center, and informing compassionate cancer care for SGM people.

Interventions

  • OTHER Patient SOGI Self-Report
  • OTHER SOGI Resource for Clinical Care Education (SORCE)
  • OTHER Cancer Center Care Environment

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2023-03-14
Est. Completion 2024-03-14

What the Registry Record Tells You About NCT05845476

The ClinicalTrials.gov registry entry for NCT05845476 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Patient SOGI Self-Report is the first listed.

NCT05845476 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05845476 about?

NCT05845476 is a clinical study titled "Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation". Sexual and gender minority (SGM) individuals experience significant cancer-related health disparities across the cancer continuum. The overall goal of this proposal is to assess multi-level barriers associated with sexual orientation and gender identity (SOGI) data collection in the health record as...

What is the current status of trial NCT05845476?

This trial is currently completed. The enrollment target is 54 participants. The study started on 2023-03-14. Estimated completion is 2024-03-14.

What interventions are being tested in trial NCT05845476?

The interventions under investigation include: Patient SOGI Self-Report (OTHER), SOGI Resource for Clinical Care Education (SORCE) (OTHER), Cancer Center Care Environment (OTHER).

Who is sponsoring clinical trial NCT05845476?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.